Shionogi
Headquarters country
Japan
Registry sponsor category
Industry
- Company name
- Shionogi
- Organisation type
- Industry
- Registered legal name
- 塩野義製薬株式会社
- US industry code (SIC)
- American depositary receipts
- Registry sponsor category
- Industry
- Website
- https://www.shionogi.com/jp/ja/
- Shionogi
- Shionogi Inc.
- SEC filer number (CIK)
- 0001281721
- Legal Entity Identifier (LEI)
- 35380049VXDTHZI3DY35
- Wikidata ID
- Q3482319
Related records
Trials (173)
- A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
- A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women
- A Clinical Study to Evaluate the Safety of Ospemifene
- A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants
- A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
- A Drug-Drug Interaction Study of S-217622 With Combined Oral Contraceptives in Healthy Adult Female Participants
- A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants
- A Long-term Study for the Treatment of Painful Diabetic Neuropathy
- A Multicenter, Phase Ib/II Clinical Trial to Evaluate the Efficacy and Safety of Concurrent Combination Therapy of S-531011 Plus Fruquintinib or S-531011 Plus Fruquintinib Plus Pembrolizumab in Patients With MSS/pMMR Colorectal Cancer
- A Phase 1 Study of S-3304 in Patients With Solid Tumors
- A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects
- A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
- A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic Dermatitis
- A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis
- A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients
- A Study for the Treatment of Diabetic Peripheral Neuropathic Pain
- A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder
- A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain
- A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan
- A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)